about
Novel therapeutics for Alzheimer's disease: an updateBeta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammationHuman microglial cells synthesize albumin in brain.Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes.In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathologyInfluence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease.Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.Microglia in neuroregeneration.Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect.Inflammation, apoptosis, and Alzheimer's disease.Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability.Regulation of microglia - potential new drug targets in the CNS.Frontiers in Alzheimer's disease therapeutics.Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol.PMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β-Induced Cognitive Deficits through Modulation of Neuroinflammation.Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme.Antioxidant therapies for Alzheimer's diseaseThe anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease.The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.Dementia of the Alzheimer type.Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegenerationA pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects.Inflammation in Alzheimer's disease: relevance to pathogenesis and therapyRoad to Alzheimer's disease: the pathomechanism underlying.Review: activation patterns of microglia and their identification in the human brain.The role of Müller glia and microglia in glaucoma.The Proteasome and Oxidative Stress in Alzheimer's Disease.DHT inhibits the Aβ25-35-induced apoptosis by regulation of seladin-1, survivin, XIAP, bax, and bcl-xl expression through a rapid PI3-K/Akt signaling in C6 glial cell lines.β-Amyloid-evoked apoptotic cell death is mediated through MKK6-p66shc pathway.Inhibitory effects of melatonin on the lipopolysaccharide-induced CC chemokine expression in BV2 murine microglial cells are mediated by suppression of Akt-induced NF-κB and STAT/GAS activity.Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide.A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand.High-content screening: flow cytometry analysis.Cerebral endothelial activation and signal transduction mechanisms during inflammation and infectious disease.High-throughput flow cytometry for drug discovery.Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.In vivo reversal of amyloid-beta lesions in rat brain.
P2860
Q24620383-6F6D71B4-E44D-4F21-87DD-3F97C1F6D5DEQ30803369-C67D98BA-EC14-49AF-BF85-7FB438A9D7CCQ33355985-E77EC794-1A01-4EFB-9224-0BDA4CE906A5Q33368728-0B45CD42-71C6-4376-BA99-0772313ACF18Q33995580-82447184-30B8-4043-A1BD-3994E1F785A4Q33998693-A461B3C3-4771-4B31-82CB-81E9C3903630Q34207080-7C6C34F6-9934-4F14-B871-980F4929F90EQ34309544-3FCA5C7A-2A7E-4FD1-87F4-79A6CFFDE6CAQ34349287-1CF1AAC0-0184-4363-9CAB-AB6B34595851Q34460952-B2FF59AC-8CA7-4BF7-BE28-1C4871CD77A9Q34682170-154B26B5-ED98-4710-BEB8-4DE3B1434F1AQ34784469-67AE72CC-36A9-4608-A1AB-7EB3376044B5Q34807482-0E36A719-9EB2-4C1A-9190-23ACC91BC5DCQ35050412-42F41B5D-491F-478B-89AA-F595C661E1B0Q35086876-15628AAA-3A25-41C7-9580-AE0122F995F4Q35235007-7151D9E3-79CD-4F88-8EF4-FEE6A133B76EQ35511034-236D2074-F223-47B2-BC0F-3AD1A32495CEQ36016766-F4D38E51-2013-42D0-B486-6D1B878C7039Q36135040-BA4C4DF9-85A9-4DBA-A222-2544264F8F1DQ36635842-0378AF8B-9120-4C3C-94FB-3163649BE5BBQ37067641-E230F7E3-F7B1-41B7-B51C-6650EFA5BE9DQ37219298-C9C49546-5878-4CBC-830B-D49EB1545D7EQ37270004-65459F04-2891-49D8-861E-DF337592AE35Q37596887-40A758E7-FA49-4FFC-B0C9-3ACE830868C9Q37685285-3D35F756-D44D-4782-BC5F-03BFF6D39360Q37972068-1B7DAD12-D3E3-43CC-AFA6-92E4AD50955CQ38068503-554EFB16-3FAB-4D65-B6F2-E03ACB9EF935Q38115460-CDD0089A-8CA7-4A59-8A76-263B000AD76EQ38843876-2637BA75-0251-44A8-B4CD-9CDD187C3225Q38944882-C14E7CD3-F1BB-4A49-9A26-FC3C517CFB43Q39089001-277DC032-1E22-4901-AA3D-273AD81EBA24Q39416403-71A80208-6249-41D0-A739-9069DD7FE34BQ40341534-45F3B589-5A73-4FBF-B6C0-D703413D74FDQ41829746-B1224268-66BB-45FB-9C3D-B84300479E9AQ42045762-25F0562E-6D52-4292-8E2D-C13EA6904CC2Q42157874-3D09C5D1-9834-4ADF-BD68-D53FBE47C2E9Q48595483-D8007687-5188-4C5B-8321-98B45E241E63Q48895750-CCAC157C-7924-4B7F-8963-0A55EBEC3F80Q53234017-FA21C0A7-883B-4504-91E9-10E9A31B1B18
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Microglia and Alzheimer's disease.
@en
Microglia and Alzheimer's disease.
@nl
type
label
Microglia and Alzheimer's disease.
@en
Microglia and Alzheimer's disease.
@nl
prefLabel
Microglia and Alzheimer's disease.
@en
Microglia and Alzheimer's disease.
@nl
P1476
Microglia and Alzheimer's disease.
@en
P2093
Kalaria RN
P356
10.1097/00062752-199901000-00004
P577
1999-01-01T00:00:00Z